Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells

Dimethyl fumarate (DMF) and its active metabolite monomethyl fumarate (MMF) effectively lead to reduction in disease relapses and active magnetic resonance imaging (MRI) lesions. DMF and MMF are known to be effective in modulating T- and B-cell responses; however, their effect on the phenotype and f...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis Jg. 25; H. 1; S. 63
Hauptverfasser:	Mazzola, Maria Antonietta, Raheja, Radhika, Regev, Keren, Beynon, Vanessa, von Glehn, Felipe, Paul, Anu, Pierre, Isabelle, Kivisakk, Pia, Weiner, Howard L, Gandhi, Roopali
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 01.01.2019
Schlagworte:	Dendritic Cells - drug effects Dimethyl Fumarate - pharmacology Fumarates - pharmacology Humans Immunologic Factors - pharmacology Multiple Sclerosis, Relapsing-Remitting - blood Multiple Sclerosis, Relapsing-Remitting - drug therapy Myeloid Cells - drug effects T-Lymphocytes - drug effects co-stimulatory molecules Multiple sclerosis dimethyl fumarate myeloid dendritic cells monomethyl fumarate NF-kB
ISSN:	1477-0970, 1477-0970
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!